Peri-Implant Tissues
8
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
CTG vs VCMX for Peri-implant Soft Tissue Thickness
Soft Tissue Management in Peri-Implant Regions
The Effect of Injectable Platelet-Rich Fibrin in Peri-implant Soft Tissue
Ten Year Follow up of Convergent Profile Implants
Flapless Mini-incision Implant Surgery
Prospective Longitudinal Clinical Study for the Evaluation of Peri-implant Tissue and Osseointegration After Rehabilitation With Osseointegrated Implants
Comparison Between Free Gingival Graft and Palatal Pedicle Flap
Evaluation of Peri-Implant Tissues of Different Implant Assisted Overdentures